Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00389090
Status:
TERMINATED
Last Update Posted:
2012-02-09
First Post:
2006-10-16
Brief Title:
A Phase II Study of Temozolomide and O6-Benzylguanine O6-BG in Patients With Temozolomide-Resistant Anaplastic Glioma
Sponsor:
Keryx AOI Pharmaceuticals Inc
Organization:
Keryx AOI Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10
Start Date Type:
None
Primary Completion Date:
2008-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-16
First Submit QC Date:
October 16 2006
Study First Post Date:
2006-10-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-02-07
Last Update Post Date:
2012-02-09
Last Update Post Date Type:
ESTIMATED